Logo

American Heart Association

  2
  0


Final ID: MDP169

Longitudinal Changes in Parent-reported Quality of Life in Children with Single Ventricle

Abstract Body (Do not enter title and authors here): Introduction: Increased knowledge of quality of life (QOL) and the potential impact of the Fontan on QOL is essential to improving outcomes in patients with single ventricle. The primary aim of the Pediatric Heart Network Single Ventricle Reconstruction (SVR) trial II was to investigate outcomes in subjects with SV at age 6 yrs while SVR III characterized outcomes in this cohort at age 10-12 yrs.
Aims: The purpose of this study was to evaluate changes in health-related QOL from SVR II to SVR III and to identify factors associated with changes in QOL over time.
Methods: Parents completed proxy-reports for their child using the Pediatric Quality of Life Inventory (PedsQL) generic and cardiac scales at SVR II and SVR III. Within-subject differences in PedsQL scores and proportions scoring in the ‘at-risk’ range for significantly impaired QOL between time points were examined using one-sample t-test and McNemar’s tests, respectively. Factors associated with changes in QOL were evaluated using standard univariate tests.
Results: A total of 163 patients were included (63% male, 89% Caucasian, 16% Hispanic). PedsQL scores reported by parents decreased across all domains: total score -6.1 ± 17.1, p <.0001; physical -4.0 ± 22.3, p=0.02; psychosocial -7.2 ± 17.4, p<.0001; emotional -6.5 ± 20.7, p=.0001; social -6.6 ± 22.6, p= 0.0003; and school -8.6 ± 22.5, p<.0001, functioning. No significant change in parent-reported heart problems/cardiac symptoms was detected across timepoints (-1.0 ± 20.4, p=0.52). Proportions with impaired QOL increased over time: total 28 to 39%, p=.01, physical 27 to 39%, p=.01, psychosocial 25 to 40%, p=.002, emotional 20 to 34%, p=.001, social 22 to 31%, p=.06, and school 21 to 38%, p=.0001. Only treatment for a psychological or behavioral disorder (n=26) was significantly associated with decline in psychosocial (mean -14.0 vs. -5.9; p=.03) and emotional (mean -17.1 vs. -4.5; p=.004) functioning scores. There was no significant association between socioeconomic status, Vineland adaptive scores at SVR II, or interval complications or procedures and changes in QOL.
Conclusion: As perceived by their parents, health-related QOL in children with SV decreases over time unrelated to cardiac symptoms and complications. The greatest decline was in school functioning with 1 in 3 children having significantly impaired school QOL at SVR III. Greater attention to assessment of learning and psychosocial needs is essential to improve QOL in patients with SV.
  • Uzark, Karen  ( University of Michigan CS Mott Children's Hospital , Ann Arbor , Michigan , United States )
  • Shah, Amee  ( Columbia University Medical Center , New York , New York , United States )
  • Sood, Erica  ( AI duPont Hospital for Children , Wilmington , Delaware , United States )
  • Suthar, Divya  ( SIBLEY HEART CENTER CARDIOLOGY , Atlanta , Georgia , United States )
  • Trachtenberg, Felicia  ( Carelon Research , Newton , Massachusetts , United States )
  • Votava-smith, Jodie  ( Children's Hospital Los Angeles , Los Angeles , California , United States )
  • Williams, Jason  ( Duke University , Durham , North Carolina , United States )
  • Newburger, Jane  ( CHILDRENS HOSPITAL BOSTON , Boston , Massachusetts , United States )
  • Goldberg, Caren  ( UNIV MICHIGAN MOTT CHILDRENS HOSP , Ann Arbor , Michigan , United States )
  • Yu, Sunkyung  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Afton, Katherine  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Atz, Andrew  ( MEDICAL UNIV SOUTH CAROLINA , Mt Pleasant , South Carolina , United States )
  • Floh, Alejandro  ( THE HOSPITAL FOR SICK CHILDREN , Toronto , Ontario , Canada )
  • Kasparian, Nadine  ( Cincinnati Childrens Hospital , Cincinnati , Ohio , United States )
  • Lambert, Linda  ( University of Utah-PCH Heart Center , Salt Lake City , Utah , United States )
  • Morrison, Tonia  ( The Children's Hospital of Phila , Swedesboro , New Jersey , United States )
  • Pemberton, Victoria  ( NHLBI , Bethesda , Maryland , United States )
  • Author Disclosures:
    Karen Uzark: DO NOT have relevant financial relationships | Amee Shah: DO NOT have relevant financial relationships | Erica Sood: DO NOT have relevant financial relationships | Divya Suthar: No Answer | Felicia Trachtenberg: No Answer | Jodie Votava-Smith: DO NOT have relevant financial relationships | Jason Williams: No Answer | Jane Newburger: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Other (please indicate in the box next to the company name):Daichii Sankyo (trial Steering Committee):Past (completed) ; Other (please indicate in the box next to the company name):BMS (Chair of DSMB for pediatric mavacamten trial):Active (exists now) ; Other (please indicate in the box next to the company name):Novartis (Chair, Independent EAC):Past (completed) ; Other (please indicate in the box next to the company name):BMS (Chair, Independent EAC):Active (exists now) ; Other (please indicate in the box next to the company name):Pfizer (Chair Independent EAC):Active (exists now) | Caren Goldberg: DO NOT have relevant financial relationships | Sunkyung Yu: DO NOT have relevant financial relationships | Katherine Afton: No Answer | Andrew Atz: DO NOT have relevant financial relationships | Alejandro Floh: DO NOT have relevant financial relationships | Nadine Kasparian: DO NOT have relevant financial relationships | Linda Lambert: DO NOT have relevant financial relationships | Tonia Morrison: DO NOT have relevant financial relationships | Victoria Pemberton: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Single Ventricle Congenital Heart Disease

Saturday, 11/16/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
Aberrant Regulation of endMT in Turner Syndrome: Implications for the Pathogenesis of Congenital Cardiovascular Disease

Garcia Huitron Eric Ivan, Zhang Xiaoying, Babcock Lance, Grande-allen Kathryn, Prakash Siddharth

A CRISPR-Activation CROP-seq Screen Identifies HMGN1 as a Dosage-Sensitive Regulator of Heart Defects in Down Syndrome

Ranade Sanjeev, Mital Rahul, Boileau Ryan, Koback Frances, Padmanabhan Arun, Merriman Alexander, Wallace Langley, Nguyen Annie, Poulis Nikolaus, Gifford Casey, Pollard Katherine, Li Feiya, Srivastava Deepak, Whalen Sean, Angelo Pelonero, Ye Lin, Huang Yu, Brand Abigail, Nishino Tomohiro, Costa Mauro

More abstracts from these authors:
The Impact of Social Determinants on Growth at 10 Years After the Norwood Procedure: Results from the Single Ventricle Reconstruction (SVR) Trial III

Pruitt Cathleen, Lupton Katherine, Mccrary Andrew, Mccrindle Brian, Mccormick Amanda, Newburger Jane, Pizarro Christian, Ravishankar Chitra, Rudd Nancy, Shah Amee, Trachtenberg Felicia, Lambert Linda, Zyblewski Sinai, Minich Luann, Ou Zhining, Goldberg Caren, Presson Angela, Aljiffry Alaa, Anderson Jeffrey, Detterich Jon, Frischhertz Benjamin

Transitions from Hospital to Home - PEDS perspective

Uzark Karen, Lambert Linda

You have to be authorized to contact abstract author. Please, Login
Not Available